John J. Boniface, Chief Scientific Officer at SERA PROGNOSTICS, INC. (SERA), sold 150,519 shares at $9.04 ($1.4M) on 2024-03-28, disclosed to the SEC on 2024-03-28.
Scheduled sale ($1.4M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.62 | 3,753 | $36K | 2.5% |
| 2 | $9.62 | 48,909 | $471K | 33.1% |
| 3 | $9.62 | 48,909 | $471K | 33.1% |
| 4 | $9.04 | 24,474 | $221K | 15.6% |
| 5 | $9.04 | 24,474 | $221K | 15.6% |
| Total | $9.43 avg | 150,519 |
| $1.4M |
| 100% |
| Filing → |
| SERA | SELL | 2025-12-11 | $4K | — | Filing → |
| SERA | SELL | 2025-11-12 | $20K | — | Filing → |
| SERA | SELL | 2025-09-12 | $4K | — | Filing → |